kras mutation and glutathion glutathione pancreatic cancer How survives ferroptosis? Pancreatic ductal adenocarcinoma (PDAC) tumors harboring mutations exhibit Promising direction for the treatment
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



